<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Patel MI</submitter><funding>NIMHD NIH HHS</funding><pagination>e2222009</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9284331</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(7)</volume><pubmed_abstract>&lt;h4>Importance&lt;/h4>The full effect of the COVID-19 pandemic on cancer care disparities, particularly by race and ethnicity, remains unknown.&lt;h4>Objectives&lt;/h4>To assess whether the race and ethnicity of patients with cancer was associated with disparities in cancer treatment delays, adverse social and economic effects, and concerns during the COVID-19 pandemic and to evaluate trusted sources of COVID-19 information by race and ethnicity.&lt;h4>Design, setting, and participants&lt;/h4>This national survey study of US adults with cancer compared treatment delays, adverse social and economic effects, concerns, and trusted sources of COVID-19 information by race and ethnicity from September 1, 2020, to January 12, 2021.&lt;h4>Exposures&lt;/h4>The COVID-19 pandemic.&lt;h4>Main outcomes and measures&lt;/h4>The primary outcome was delay in cancer treatment by race and ethnicity. Secondary outcomes were duration of delay, adverse social and economic effects, concerns, and trusted sources of COVID-19 information.&lt;h4>Results&lt;/h4>Of 1639 invited respondents, 1240 participated (75.7% response rate) from 50 US states, the District of Columbia, and 5 US territories (744 female respondents [60.0%]; median age, 60 years [range, 24-92 years]; 266 African American or Black [hereafter referred to as Black] respondents [21.5%]; 186 Asian respondents [15.0%]; 232 Hispanic or Latinx [hereafter referred to as Latinx] respondents [18.7%]; 29 American Indian or Alaska Native, Native Hawaiian, or multiple races [hereafter referred to as other] respondents [2.3%]; and 527 White respondents [42.5%]). Compared with White respondents, Black respondents (odds ratio [OR], 6.13 [95% CI, 3.50-10.74]) and Latinx respondents (OR, 2.77 [95% CI, 1.49-5.14]) had greater odds of involuntary treatment delays, and Black respondents had greater odds of treatment delays greater than 4 weeks (OR, 3.13 [95% CI, 1.11-8.81]). Compared with White respondents, Black respondents (OR, 4.32 [95% CI, 2.65-7.04]) and Latinx respondents (OR, 6.13 [95% CI, 3.57-10.53]) had greater odds of food insecurity and concerns regarding food security (Black respondents: OR, 2.02 [95% CI, 1.34-3.04]; Latinx respondents: OR, 2.94 [95% CI, [1.86-4.66]), financial stability (Black respondents: OR, 3.56 [95% CI, 1.79-7.08]; Latinx respondents: OR, 4.29 [95% CI, 1.98-9.29]), and affordability of cancer treatment (Black respondents: OR, 4.27 [95% CI, 2.20-8.28]; Latinx respondents: OR, 2.81 [95% CI, 1.48-5.36]). Trusted sources of COVID-19 information varied significantly by race and ethnicity.&lt;h4>Conclusions and relevance&lt;/h4>In this survey of US adults with cancer, the COVID-19 pandemic was associated with treatment delay disparities and adverse social and economic effects among Black and Latinx adults. Partnering with trusted sources may be an opportunity to overcome such disparities.</pubmed_abstract><journal>JAMA network open</journal><pubmed_title>Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic.</pubmed_title><pmcid>PMC9284331</pmcid><funding_grant_id>K23 MD013474</funding_grant_id><funding_grant_id>R21 MD013674</funding_grant_id><pubmed_authors>Castro E</pubmed_authors><pubmed_authors>Bondy M</pubmed_authors><pubmed_authors>Armaiz-Pena GN</pubmed_authors><pubmed_authors>Infantado A</pubmed_authors><pubmed_authors>Ferguson JM</pubmed_authors><pubmed_authors>Julian D</pubmed_authors><pubmed_authors>Maingi S</pubmed_authors><pubmed_authors>Nortey N</pubmed_authors><pubmed_authors>Duron Y</pubmed_authors><pubmed_authors>Pereira-Estremera CD</pubmed_authors><pubmed_authors>Steck A</pubmed_authors><pubmed_authors>Hlubocky F</pubmed_authors><pubmed_authors>Nuqui B</pubmed_authors><pubmed_authors>Patel MI</pubmed_authors></additional><is_claimable>false</is_claimable><name>Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic.</name><description>&lt;h4>Importance&lt;/h4>The full effect of the COVID-19 pandemic on cancer care disparities, particularly by race and ethnicity, remains unknown.&lt;h4>Objectives&lt;/h4>To assess whether the race and ethnicity of patients with cancer was associated with disparities in cancer treatment delays, adverse social and economic effects, and concerns during the COVID-19 pandemic and to evaluate trusted sources of COVID-19 information by race and ethnicity.&lt;h4>Design, setting, and participants&lt;/h4>This national survey study of US adults with cancer compared treatment delays, adverse social and economic effects, concerns, and trusted sources of COVID-19 information by race and ethnicity from September 1, 2020, to January 12, 2021.&lt;h4>Exposures&lt;/h4>The COVID-19 pandemic.&lt;h4>Main outcomes and measures&lt;/h4>The primary outcome was delay in cancer treatment by race and ethnicity. Secondary outcomes were duration of delay, adverse social and economic effects, concerns, and trusted sources of COVID-19 information.&lt;h4>Results&lt;/h4>Of 1639 invited respondents, 1240 participated (75.7% response rate) from 50 US states, the District of Columbia, and 5 US territories (744 female respondents [60.0%]; median age, 60 years [range, 24-92 years]; 266 African American or Black [hereafter referred to as Black] respondents [21.5%]; 186 Asian respondents [15.0%]; 232 Hispanic or Latinx [hereafter referred to as Latinx] respondents [18.7%]; 29 American Indian or Alaska Native, Native Hawaiian, or multiple races [hereafter referred to as other] respondents [2.3%]; and 527 White respondents [42.5%]). Compared with White respondents, Black respondents (odds ratio [OR], 6.13 [95% CI, 3.50-10.74]) and Latinx respondents (OR, 2.77 [95% CI, 1.49-5.14]) had greater odds of involuntary treatment delays, and Black respondents had greater odds of treatment delays greater than 4 weeks (OR, 3.13 [95% CI, 1.11-8.81]). Compared with White respondents, Black respondents (OR, 4.32 [95% CI, 2.65-7.04]) and Latinx respondents (OR, 6.13 [95% CI, 3.57-10.53]) had greater odds of food insecurity and concerns regarding food security (Black respondents: OR, 2.02 [95% CI, 1.34-3.04]; Latinx respondents: OR, 2.94 [95% CI, [1.86-4.66]), financial stability (Black respondents: OR, 3.56 [95% CI, 1.79-7.08]; Latinx respondents: OR, 4.29 [95% CI, 1.98-9.29]), and affordability of cancer treatment (Black respondents: OR, 4.27 [95% CI, 2.20-8.28]; Latinx respondents: OR, 2.81 [95% CI, 1.48-5.36]). Trusted sources of COVID-19 information varied significantly by race and ethnicity.&lt;h4>Conclusions and relevance&lt;/h4>In this survey of US adults with cancer, the COVID-19 pandemic was associated with treatment delay disparities and adverse social and economic effects among Black and Latinx adults. Partnering with trusted sources may be an opportunity to overcome such disparities.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-04-21T22:28:23.457Z</modification><creation>2025-04-05T18:48:16.704Z</creation></dates><accession>S-EPMC9284331</accession><cross_references><pubmed>35834248</pubmed><doi>10.1001/jamanetworkopen.2022.22009</doi></cross_references></HashMap>